Leveraging existing large breast cancer databases and cohorts with genomic and transcriptomic profiles as well as clinical data, we were able to develop a systematic data mining strategy to identify COX-2-associated genes in TNBC that are correlated with its aggressive features and breast cancer resistance to COX-2 inhibitor. Here, PTGS2 is linked to breast carcinoma.